Kazushi Araki
-
- Acute Myeloid Leukemia Research 3
-
- Peroxisome Proliferator-Activated Receptors 8
- Metabolism, Diabetes, and Cancer 8
- Epigenetics and DNA Methylation 5
- Histone Deacetylase Inhibitors Research 5
- Cancer-related gene regulation 4
- Bioactive natural compounds 2
-
- T-cell and Retrovirus Studies 4
- Co-authors
- Daisuke HonmaJun OhsumiKensei TobinaiNobuaki AdachiKaoru UchimaruKunihiro TsukasakiAtae UtsunomiyaMakoto Yamagishi
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Kazushi Araki
23 papers receiving 374 citations
Peers
Comparison fields: 5 of 55
- Hematology 57
- Molecular Biology 264
- Immunology 78
- Agronomy and Crop Science 32
- Cancer Research 42
Countries citing papers authored by Kazushi Araki
This map shows the geographic impact of Kazushi Araki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazushi Araki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazushi Araki more than expected).
Fields of papers citing papers by Kazushi Araki
This network shows the impact of papers produced by Kazushi Araki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazushi Araki. The network helps show where Kazushi Araki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazushi Araki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2021 | 17 | |
| 4 | 2019 | 128 | |
| 5 | 2019 | 12 | |
| 6 | 2018 | 7 | |
| 7 | 2018 | 11 | |
| 8 | 2018 | 20 | |
| 9 | 2017 | 2 | |
| 10 | The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model | 2016 | 0 |
| 11 | 2016 | 9 | |
| 12 | 2015 | 45 | |
| 13 | 2015 | 1 | |
| 14 | 2012 | 13 | |
| 15 | 2011 | 16 | |
| 16 | 2011 | 16 | |
| 17 | 2010 | 16 | |
| 18 | 2009 | 26 | |
| 19 | 2008 | 8 | |
| 20 | 2006 | 11 |
About Kazushi Araki
Kazushi Araki is a scholar working on Hematology, Genetics and Molecular Biology, having authored 24 papers that have together received 379 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (8 papers), Metabolism, Diabetes, and Cancer (8 papers), Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (5 papers), T-cell and Retrovirus Studies (4 papers), Cancer-related gene regulation (4 papers), Acute Myeloid Leukemia Research (3 papers) and Bioactive natural compounds (2 papers). The work is most often cited by research in Hematology (57 citations), Molecular Biology (264 citations) and Immunology (78 citations). Kazushi Araki has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Daisuke Honma, Jun Ohsumi, Kensei Tobinai, Nobuaki Adachi, Kaoru Uchimaru, Kunihiro Tsukasaki, Atae Utsunomiya, Makoto Yamagishi, Dai Fujikawa and Yuetsu Tanaka. Their work appears in journals such as Blood, Cancer Research and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.